Rain Oncology Inc (DELISTED) (RAIN:DL)
1.21
0.00 (0.00%)
USD |
NASDAQ |
Jan 26, 16:00
Rain Oncology Total Liabilities (Quarterly): 14.54M for Sept. 30, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 14.54M |
| June 30, 2023 | 18.43M |
| March 31, 2023 | 19.62M |
| December 31, 2022 | 22.14M |
| September 30, 2022 | 13.23M |
| June 30, 2022 | 12.38M |
| Date | Value |
|---|---|
| March 31, 2022 | 13.33M |
| December 31, 2021 | 16.64M |
| September 30, 2021 | 11.26M |
| June 30, 2021 | 9.719M |
| March 31, 2021 | 100.55M |
| December 31, 2020 | 98.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.719M
Minimum
Jun 2021
100.55M
Maximum
Mar 2021
29.19M
Average
15.59M
Median
Total Liabilities (Quarterly) Benchmarks
| Icosavax Inc (DELISTED) | 18.92M |
| AbbVie Inc | 140.83B |
| Cerevel Therapeutics Holdings Inc | 562.89M |
| CEL-SCI Corp | 16.06M |
| AIM ImmunoTech Inc | 9.147M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.06M |
| Shareholders Equity (Quarterly) | 67.52M |